Fund Holdings — Decheng Capital LLC

Total Portfolio Value:
$395.97M
Total Bought:
$5.96M
Total Sold:
$22.89M
Net Transaction:
-$16.93M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)6,371,6696,371,6690$156.04M$165.66M41.84%+$9.62M
Aardvark Therapeutics Inc3,917,2993,917,2990$29.42M$52.96M13.38%+$23.54M
Nuvation Bio Inc.(NUVB)25,954,43925,954,4390$45.68M$50.61M12.78%+$4.93M
Upstream Bio, Inc.(UPB)3,285,2933,285,2930$20.11M$36.07M9.11%+$15.97M
Newamsterdam Pharma Co Nv
ORDINARY SHARES
770,000770,0000$15.76M$13.94M3.52%-$1.82M
BeyondSpring Inc.SHS(BYSI)4,882,6514,531,481-351,170$6.97M$10.65M2.69%+$3.68M
Merus Nv189,098189,0980$7.96M$9.95M2.51%+$1.99M
Krystal Biotech, Inc.(KRYS)65,00066,000+1,000$11.72M$9.07M2.29%-$2.65M
Moonlake Immunotherapeutics171,600181,600+10,000$6.70M$8.57M2.16%+$1.87M
Revolution Medicines, Inc.(RVMD)226,000226,0000$7.99M$8.31M2.10%+$323.2K
Aclaris Therapeutics, Inc.(ACRS)4,041,7364,041,7360$6.18M$5.74M1.45%-$444.6K
Lyell Immunopharma, Inc.(LYEL)11,909,341595,466-11,313,875$6.41M$5.26M1.33%-$1.14M
Arcellx Inc
COMMON STOCK
50,000547,609+497,609$3.28M$4.46M1.13%+$1.18M
Crinetics Pharmaceuticals In177,958143,000-34,958$5.97M$4.11M1.04%-$1.86M
Aura Biosciences, Inc.(AURA)515,555515,5550$3.02M$3.23M0.82%+$206.2K
Zentalis Pharmaceuticals, Inc.(ZNTL)2,019,7621,323,327-696,435$3.21M$1.54M0.39%-$1.68M
Equillium, Inc.(EQ)4,447,3084,447,3080$1.74M$1.40M0.35%-$342.9K
4d Molecular Therapeutics In335,515239,510-96,005$1.08M$888.6K0.22%-$195.1K
Arcus Biosciences, Inc.(RCUS)808,789160,000-648,789$6.35M$811.2K0.20%-$5.54M
Illumina, Inc.(ILMN)11,7497,979-3,770$932.2K$761.3K0.19%-$170.9K
Legend Biotech CorporationADR(LEGN)100,00020,000-80,000$3.39M$709.8K0.18%-$2.68M
GRAIL, Inc.(GRAL)9,6849,6840$247.3K$498.0K0.13%+$250.6K
Pyxis Oncology, Inc.(PYXS)326,810326,8100$320.2K$359.5K0.09%+$39.3K
Rezolute, Inc.(RZLT)059,900+59,900$0$267.2K0.07%+$267.2K
Nuvation Bio Inc.WARRANTS(NUVB)646,057646,0570$44.0K$127.3K0.03%+$83.4K
BioNTech SE(BNTX)20,0000-20,000$1.82M$0—-$1.82M
Cytokinetics, Incorporated(CYTK)100,0000-100,000$4.02M$0—-$4.02M
Vera Therapeutics, Inc.(VERA)4,4950-4,495$108.0K$0—-$108.0K
Page 1 of 1
Decheng Capital LLC — 13F Holdings — Q2 2025 | TickerTrail